Reckitt Benckiser Group PLC (RKT) has announced that Shannon Eisenhardt, its Chief Financial Officer and Executive Director, has been appointed as a Non-Executive Director of United Parcel Service, Inc. (UPS), effective 4 November 2026. Eisenhardt will also serve as a member of UPS's Audit Committee. The disclosure was made in accordance with UK Listing Rule 6.4.9R(2), which requires listed companies to notify the market of external directorships held by executive directors. Investors may be watching to assess whether the additional commitment affects Eisenhardt's availability in her primary role at Reckitt.

Key Points

  • Reckitt Benckiser Group PLC (RKT) — FTSE-listed global consumer health and hygiene company
  • CFO Shannon Eisenhardt appointed Non-Executive Director of United Parcel Service, Inc., effective 4 November 2026
  • Eisenhardt will join UPS's Audit Committee alongside her Non-Executive Director role
  • Investors should watch for any further regulatory disclosures or board composition updates at Reckitt

Shannon Eisenhardt's Dual Role: Reckitt CFO Takes Seat on UPS Board and Audit Committee

Reckitt's announcement confirms that Shannon Eisenhardt, who serves as both Chief Financial Officer and Executive Director of Reckitt Benckiser Group PLC, has accepted a Non-Executive Director position at United Parcel Service, Inc., one of the world's largest logistics companies. Alongside this board appointment, Eisenhardt has also been named a member of UPS's Audit Committee, a role that typically carries significant oversight responsibilities relating to financial reporting and internal controls. The appointment took effect on 4 November 2026. No remuneration details for the UPS role were disclosed in the announcement.

UK Listing Rule 6.4.9R(2) Disclosure Obligation Triggers Reckitt's Regulatory Notification

The notification was made specifically in accordance with UK Listing Rule 6.4.9R(2), which obliges premium and certain other listed companies to publicly disclose when an executive director takes on an external directorship. This regulatory requirement ensures transparency for shareholders regarding potential conflicts of interest or time commitments that could affect senior leadership capacity. Reckitt's compliance with this listing rule reflects standard governance practice for companies listed on the London Stock Exchange. The company did not disclose any further detail regarding Reckitt's board approval process for the external appointment.

Reckitt's Global Consumer Health Portfolio and Scale Provide Context for CFO's Profile

Founded in 1840 in the United Kingdom, Reckitt operates in more than 80 countries and sells approximately 30 million products every day, employing around 36,000 people worldwide. The company's portfolio spans Germ Protection, Household Care, Intimate Wellness, and Self Care, with globally recognised brands including Dettol, Durex, Finish, Gaviscon, Nurofen, Mucinex, Strepsils, Vanish, and Veet. Reckitt describes its mission as delivering better health in more hands every day, underpinned by science-led innovation and consumer insight across its diversified product categories.